Free Trial

Best Biotechnology Stocks

Biotech stocks open the door to investing in innovation that’s shaping the future of healthcare. From pioneering drug developers to specialized firms in genetic engineering and diagnostics, this sector offers exposure to breakthroughs with the potential for transformative impact—and strong returns. These stocks are known for their potential for high growth but also come with significant volatility due to the complex nature of biotechnological development and regulatory environments.

The list below highlights some of the most widely followed biotech stocks in today’s market. It features a range of companies—from established leaders with approved therapies to up-and-coming firms advancing promising clinical pipelines. View each stock's current price, PE ratio, volume, and recent indicators of potential movement.

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceP/E RatioMarket CapVolumeAverage VolumeIndicator(s)
AbbVie Inc. stock logo
ABBV
AbbVie
$196.82
+4.1%
83.70$347.44 billion5.02 million6.85 millionTrending News
Earnings Report
Analyst Forecast
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$462.56
-1.1%
26.73$174.46 billion2.07 million2.53 millionPositive News
Danaher Corporation stock logo
DHR
Danaher
$196.31
-0.4%
41.77$140.56 billion4.20 million4.30 millionPositive News
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
$463.24
+1.4%
N/A$118.73 billion1.06 million1.52 millionPositive News
Upcoming Earnings
Short Interest ↑
GSK PLC Sponsored ADR stock logo
GSK
GSK
$37.47
+0.8%
17.33$76.44 billion2.50 million5.36 millionEarnings Report
Dividend Cut
Cencora, Inc. stock logo
COR
Cencora
$287.96
+0.7%
33.41$55.81 billion727,8681.57 millionPositive News
Upcoming Earnings
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$398.41
+1.6%
N/A$51.88 billion1.24 million922,729Trending News
Analyst Forecast
Veeva Systems Inc. stock logo
VEEV
Veeva Systems
$280.89
-1.2%
59.56$45.94 billion624,4701.33 millionPositive News
Short Interest ↑
Takeda Pharmaceutical Co. stock logo
TAK
Takeda Pharmaceutical
$14.18
+3.3%
47.25$45.10 billion4.51 million2.42 millionGap Up
argenex SE stock logo
ARGX
argenex
$673.00
+0.4%
41.46$41.13 billion520,914373,756News Coverage
Earnings Report
Analyst Forecast
Cognizant Technology Solutions Corporation stock logo
CTSH
Cognizant Technology Solutions
$70.49
-1.8%
14.33$34.75 billion2.95 million3.79 millionPositive News
Earnings Report
Dividend Announcement
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$182.52
-1.8%
26.42$31.03 billion963,1842.03 million
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
$106.80
-0.7%
N/A$25.65 billion560,767950,479Upcoming Earnings
Gap Down
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
$37.11
+0.8%
20.07$20.87 billion1.08 million4.43 millionNews Coverage
Positive News
Upcoming Earnings
International Flavors & Fragrances Inc. stock logo
IFF
International Flavors & Fragrances
$69.51
-2.1%
N/A$17.79 billion927,8731.72 millionNews Coverage
Upcoming Earnings
Dividend Announcement
Illumina, Inc. stock logo
ILMN
Illumina
$94.75
-7.8%
N/A$15.02 billion3.49 million2.40 millionTrending News
Earnings Report
Analyst Forecast
Gap Down
Icon Plc stock logo
ICLR
Icon
$165.25
-2.3%
17.01$13.35 billion754,1741.33 million
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
$295.62
+7.6%
11.50$13.29 billion693,057497,338News Coverage
Earnings Report
Analyst Forecast
Short Interest ↑
Analyst Revision
Gap Up
Suzano S.A. Sponsored ADR stock logo
SUZ
Suzano
$9.31
+0.5%
N/A$12.33 billion1.91 million1.90 millionUpcoming Earnings
Analyst Downgrade
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$423.01
-1.0%
31.42$11.87 billion332,463462,756Analyst Downgrade
Insider Trade
Fabrinet stock logo
FN
Fabrinet
$313.41
-3.2%
34.94$11.24 billion380,968710,727Positive News
Gap Down
Moderna, Inc. stock logo
MRNA
Moderna
$27.30
-7.7%
N/A$10.52 billion12.89 million10.94 millionTrending News
Earnings Report
Analyst Forecast
Options Volume
Gap Down
Revvity Inc. stock logo
RVTY
Revvity
$87.56
-0.4%
37.08$10.31 billion890,0641.19 millionEarnings Report
Analyst Forecast
Analyst Revision
Bloom Energy Corporation stock logo
BE
Bloom Energy
$36.89
-1.3%
N/A$8.57 billion15.13 million7.03 millionTrending News
Earnings Report
Analyst Forecast
Gap Down
High Trading Volume
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$166.82
-1.7%
N/A$8.19 billion492,2981.29 millionPositive News
Upcoming Earnings
Lumentum Holdings Inc. stock logo
LITE
Lumentum
$106.37
-3.4%
N/A$7.38 billion1.82 million2.50 millionPositive News
Insider Trade
Gap Down
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
$38.56
-1.3%
N/A$7.08 billion664,4351.51 millionPositive News
Bio-Rad Laboratories, Inc. stock logo
BIO.B
Bio-Rad Laboratories
$247.05
N/A$6.72 billion4442News Coverage
Positive News
Earnings Report
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
$35.01
-1.4%
146.23$5.57 billion1.53 million2.41 millionPositive News
Upcoming Earnings
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
$132.98
+0.2%
N/A$5.45 billion1.51 million1.63 million
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
$72.39
+0.9%
N/A$4.61 billion996,314608,578Analyst Forecast
Gap Down
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
$157.89
+2.6%
37.84$4.55 billion372,082317,911Upcoming Earnings
Vaxcyte, Inc. stock logo
PCVX
Vaxcyte
$33.15
-2.4%
N/A$4.28 billion674,0281.80 millionNews Coverage
Positive News
Upcoming Earnings
ODDITY Tech Ltd. stock logo
ODD
ODDITY Tech
$71.07
+1.4%
40.75$3.96 billion1.44 million828,217News Coverage
Upcoming Earnings
Analyst Forecast
Hercules Capital, Inc. stock logo
HTGC
Hercules Capital
$19.08
+1.7%
14.34$3.35 billion1.35 million1.21 millionNews Coverage
Positive News
Earnings Report
Dividend Increase
Analyst Forecast
Ascentage Pharma Group International - Unsponsored ADR stock logo
AAPG
Ascentage Pharma Group International
$37.20
+0.5%
N/A$3.25 billion9,35643,946
Tutor Perini Corporation stock logo
TPC
Tutor Perini
$45.68
-5.1%
N/A$2.41 billion480,092666,201Upcoming Earnings
Gap Down
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
$5.68
-4.6%
N/A$2.30 billion15.47 million25.38 millionUpcoming Earnings
Gap Down
Standex International Corporation stock logo
SXI
Standex International
$182.26
+10.6%
36.14$2.21 billion180,49985,637News Coverage
Earnings Report
Analyst Forecast
Gap Up
High Trading Volume
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
$2.38
-3.5%
N/A$2.10 billion5.64 million7.71 millionNews Coverage
Gap Down
Why AMZN, GOOG, MSFT might destroy NVDA (Ad)

Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.

Click to get the full details on Eric Fry's "Nvidia alternative" right here.
JPMorgan U.S. Tech Leaders ETF stock logo
JTEK
JPMorgan U.S. Tech Leaders ETF
$82.35
-2.8%
47.07$2.05 billion424,475246,470Positive News
Short Interest ↑
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
$33.42
-0.4%
N/A$2.00 billion844,0041.08 millionUpcoming Earnings
Short Interest ↑
Gap Down
Redwire Corporation stock logo
RDW
Redwire
$13.92
-2.6%
N/A$1.99 billion2.52 million2.55 millionUpcoming Earnings
Gap Down
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
$13.56
-2.0%
N/A$1.97 billion1.10 million1.37 millionNews Coverage
Upcoming Earnings
Amicus Therapeutics, Inc. stock logo
FOLD
Amicus Therapeutics
$6.34
+5.8%
N/A$1.95 billion3.95 million3.83 millionNews Coverage
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
$18.87
-4.3%
N/A$1.89 billion2.12 million2.04 millionUpcoming Earnings
Insider Trade
Gap Down
Healthcare Triangle, Inc. stock logo
HCTI
Healthcare Triangle
$4.37
-43.8%
N/A$1.80 billion4.45 million993,253News Coverage
Gap Down
Trading Halted
High Trading Volume
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
$37.86
-1.0%
N/A$1.74 billion463,738760,363Positive News
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
$8.01
-1.7%
N/A$1.68 billion5.23 million3.86 millionUpcoming Earnings
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
$33.09
+1.0%
N/A$1.67 billion301,060337,476News Coverage
Upcoming Earnings
10x Genomics stock logo
TXG
10x Genomics
$13.03
-3.2%
N/A$1.60 billion1.84 million3.42 millionUpcoming Earnings
Analyst Forecast
Short Interest ↑
Gap Down
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
$10.38
+1.4%
N/A$1.58 billion1.02 million1.99 millionPositive News
Upcoming Earnings
Gap Down
Phreesia, Inc. stock logo
PHR
Phreesia
$26.46
-1.9%
N/A$1.57 billion280,371504,612Gap Down
Celcuity, Inc. stock logo
CELC
Celcuity
$39.78
+1.5%
N/A$1.55 billion1.15 million534,378Insider Trade
Analyst Revision
High Trading Volume
Azenta, Inc. stock logo
AZTA
Azenta
$32.52
-0.6%
N/A$1.49 billion227,506761,509News Coverage
Upcoming Earnings
MENS
Jyong Biotech
$19.00
-0.3%
N/A$1.44 billion91,695218,040Positive News
Quiet Period Expiration
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
$10.06
+2.1%
N/A$1.44 billion1.93 million2.57 millionNews Coverage
Earnings Report
Analyst Forecast
Analyst Revision
Evotec AG stock logo
EVO
Evotec
$4.01
+0.8%
N/A$1.43 billion24,336100,619News Coverage
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
$17.42
-0.6%
N/A$1.42 billion404,155896,397News Coverage
Short Interest ↑
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
$8.57
+5.8%
N/A$1.34 billion1.06 million1.29 millionNews Coverage
Earnings Report
Analyst Forecast
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
$20.95
+0.8%
N/A$1.33 billion731,3111.28 millionNews Coverage
Positive News
Upcoming Earnings
Short Interest ↑
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
$11.32
-0.9%
N/A$1.29 billion836,3792.03 millionUpcoming Earnings
Cidara Therapeutics, Inc. stock logo
CDTX
Cidara Therapeutics
$62.91
-0.6%
N/A$1.27 billion200,394369,493Upcoming Earnings
Oaktree Specialty Lending Corp. stock logo
OCSL
Oaktree Specialty Lending
$13.55
-2.0%
104.44$1.20 billion561,332720,350Positive News
Upcoming Earnings
Novavax, Inc. stock logo
NVAX
Novavax
$6.58
-1.0%
2.48$1.06 billion3.86 million6.41 millionUpcoming Earnings
Gap Down
Spyre Therapeutics, Inc. stock logo
SYRE
Spyre Therapeutics
$16.32
-3.8%
N/A$986.36 million316,701624,949News Coverage
Positive News
Upcoming Earnings
Gap Down
Immunome, Inc. stock logo
IMNM
Immunome
$10.62
+1.0%
N/A$924.94 million328,1431.04 millionNews Coverage
Positive News
Gap Down
Thermon Group Holdings, Inc. stock logo
THR
Thermon Group
$27.37
-3.2%
17.45$910.44 million81,802181,932Upcoming Earnings
Urogen Pharma stock logo
URGN
Urogen Pharma
$19.53
+2.4%
N/A$903.76 million735,7271.60 millionNews Coverage
Upcoming Earnings
Insider Trade
Gap Down
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
$2.65
+2.9%
N/A$889.92 million13.10 million13.52 millionUpcoming Earnings
Gap Down
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
$3.95
-2.8%
N/A$888.38 million3.38 million5.84 millionNews Coverage
Upcoming Earnings
Gap Down
ZYME
Zymeworks
$12.58
+0.2%
N/A$876.57 million480,683535,938
Zymeworks Inc. stock logo
ZYME
Zymeworks
$12.56
+0.0%
N/A$874.87 million482,620535,938Upcoming Earnings
abrdn Healthcare Investors stock logo
HQH
abrdn Healthcare Investors
$15.74
+0.6%
N/A$846.95 million138,558213,615Positive News
Upstream Bio, Inc. stock logo
UPB
Upstream Bio
$15.46
+0.9%
N/A$829.55 million342,227343,293Upcoming Earnings
Gap Down
ProKidney Corp. stock logo
PROK
ProKidney
$2.81
+1.4%
N/A$812.24 million928,3165.98 millionUpcoming Earnings
Gap Down
Diversified Healthcare Trust stock logo
DHC
Diversified Healthcare Trust
$3.28
+0.2%
N/A$790.09 million495,398957,910Positive News
Upcoming Earnings
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
$24.58
+0.1%
N/A$721.19 million192,563787,252News Coverage
Upcoming Earnings
Tango Therapeutics, Inc. stock logo
TNGX
Tango Therapeutics
$6.62
+9.5%
N/A$718.63 million4.77 million1.76 millionUpcoming Earnings
Gap Down
High Trading Volume
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
$12.13
-7.7%
N/A$709.41 million1.10 million1.52 millionGap Down
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
$7.81
-2.8%
N/A$698.50 million1.34 million1.11 millionUpcoming Earnings
Transcat, Inc. stock logo
TRNS
Transcat
$74.62
-2.4%
47.85$695.77 million36,103106,327Upcoming Earnings
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
$5.02
-1.1%
N/A$693.26 million500,5821.60 millionNews Coverage
Upcoming Earnings
Short Interest ↑
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
$20.59
-0.4%
N/A$662.01 million284,312316,845Upcoming Earnings
Blackrock Tcp Capital Corp. stock logo
TCPC
Blackrock Tcp Capital
$7.12
-0.8%
N/A$604.21 million377,482581,733News Coverage
Positive News
Upcoming Earnings
Replimune Group, Inc. stock logo
REPL
Replimune Group
$7.41
+5.3%
N/A$576.96 million7.28 million3.89 millionTrending News
Analyst Upgrade
Options Volume
Gap Down
Tourmaline Bio, Inc. stock logo
TRML
Tourmaline Bio
$22.03
-0.5%
N/A$566.24 million107,986299,775Upcoming Earnings
Tyra Biosciences, Inc. stock logo
TYRA
Tyra Biosciences
$10.48
-4.1%
N/A$559.83 million143,102312,890Upcoming Earnings
Short Interest ↑
Septerna, Inc. stock logo
SEPN
Septerna
$12.21
-1.6%
N/A$544.28 million157,112720,307
Arvinas, Inc. stock logo
ARVN
Arvinas
$7.37
-1.0%
N/A$538.96 million951,4342.17 millionNews Coverage
Upcoming Earnings
Alex’s “Next Magnificent Seven” stocks (Ad)

The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Magnificent Seven—seven stocks he believes could deliver similar gains in under six years. His full breakdown is now live.

Watch the “Next Magnificent Seven” presentation here
Prime Medicine, Inc. stock logo
PRME
Prime Medicine
$3.94
+5.2%
N/A$530.32 million3.28 million2.38 millionGap Down
Rapport Therapeutics, Inc. stock logo
RAPP
Rapport Therapeutics
$14.25
-0.7%
N/A$522.47 million62,062189,686
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
$13.70
+0.8%
N/A$515.70 million78,454256,715Upcoming Earnings
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
$5.46
-5.0%
N/A$492.77 million815,8482.37 millionTrending News
Upcoming Earnings
Gap Up
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$1.30
-2.6%
N/A$491.87 million1.20 million1.80 millionPositive News
Gap Down
PureTech Health PLC Sponsored ADR stock logo
PRTC
PureTech Health
$18.40
-1.6%
N/A$441.85 million6554,430Gap Down
REGENXBIO Inc. stock logo
RGNX
REGENXBIO
$8.27
-2.8%
N/A$415.53 million368,887991,474News Coverage
Upcoming Earnings
Gap Down
Runway Growth Finance Corp. stock logo
RWAY
Runway Growth Finance
$10.55
-1.9%
6.35$393.86 million113,824321,946Positive News
Upcoming Earnings
Wabash National Corporation stock logo
WNC
Wabash National
$9.58
-3.9%
N/A$392.21 million371,2021.02 millionNews Coverage
Earnings Report
Analyst Revision
Gap Down
Rigel Pharmaceuticals, Inc. stock logo
RIGL
Rigel Pharmaceuticals
$21.80
+3.5%
10.54$389.79 million107,854220,611Upcoming Earnings

Biotech Stocks Frequently Asked Questions

Biotech stocks represent shares of companies in the biotechnology sector, which focuses on using biological processes, organisms, or systems to develop products that improve health, fight diseases, and benefit the environment. This sector includes companies that work on drug development, genetic research, biologically derived materials, and more. Due to the innovative and often breakthrough nature of their work, biotech stocks are known for their volatility but also for their potential to offer substantial returns.

Prominent players in the biotech sector include large, well-established companies such as Amgen, Gilead Sciences, and Biogen, which have multiple products on the market and solid research pipelines. Younger companies like Moderna and Regeneron are also notable, especially for their roles in developing treatments and vaccines at an accelerated pace in response to global health crises. These companies represent a mix of stable investments and high-growth potentials within the biotech industry.

While biotech exists in other areas, the majority of the biotech stocks are in the medical and agricultural sectors. Investors might choose individual stocks of companies they believe have potential based on their pipelines or existing products. However, due to the high risk associated with the biotech sector, many opt to diversify their exposure through biotech ETFs or mutual funds, which include a range of companies from startups to established leaders. This strategy can mitigate some of the risks while allowing investors to benefit from the sector's overall growth.

Before investing in biotech stocks, consider the unique risks of this sector, including high development costs, regulatory hurdles, and the binary nature of clinical trial results, which can dramatically affect a company's stock price. Investors should be prepared for volatility and have a tolerance for risk. It is also crucial to research and understand the specific focus areas of biotech companies, as these can vary widely from medical devices and pharmaceuticals to agricultural and environmental biotechnologies. Consulting with a financial advisor who understands the biotech sector can provide valuable insights and guidance tailored to your financial goals.